ADAMTS13 and Genetic thrombotic microangiopathy: ADAMTS13 activity is typically normal or only slightly reduced (by more than 20%) in other forms of thrombotic microangiopathy that are secondary to hematopoietic progenitor cell transplantation, infection, disseminated malignancy, or hemolytic uremic syndrome.